Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve Notice is hereby given pursuant to Regulation 29 read with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, that the meeting of the Board of Directors of Fredun Pharmaceuticals Limited is scheduled to be held on Friday, 30th May, 2025 inter alia, to consider and approve the following: 1. Consider and approve Audited Financial Results & Statements (Standalone & Consolidated) for the fourth quarter and financial year ended 31st March, 2025. 2. Consider and recommend final dividend on the paid-up equity shares for the Financial Year ended 31st March, 2025. Further, as per Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in Securities of the Company shall remain closed until the expiry of 48 hours after the declaration of the said Financial Results.